Author:
Hassan Maha Ali,Abdelhameed Mohamed Ayman,Abd El-Naem Mostafa Mahmoud,Abdelhafeez Mohamed Helmy
Abstract
Abstract
Background
Substance use disorders (SUD) are considered as serious mental illnesses, with variability of age of onset, duration of illness, and type of used substance among patients. The effect of type and number of substances used on the severity of such an illness are worth scientific investigation.
In this study, we tried to investigate the probable relationship between type and number of used substances with the degree of severity of substance used disorders in a sample of upper Egyptian patients. To predict risk factors associated with the severity of SUD.
Results
Opiates (including tramadol) were the most frequently used substances followed by cannabis and then heroin. Patients using poly substances scored significantly higher than the ones using a single substance on AIS (p = 0.001), as well as on the legal, drug, and family and social subscales of ASI (0.012 0.006, 0.002 respectively). Multiple stepwise linear regression analysis demonstrated that the number of used substances was the most prominent factor in determining severity of substance-related disorder.
Conclusions
Using more than one substance is common in patients with substance use disorders. This is usually associated in more severe form and consequences of illness. So, some substances and combinations are associated with more morbidity than others.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Clinical Neurology,General Neuroscience,Phychiatric Mental Health,Surgery
Reference28 articles.
1. Sdrulla AD, Chen G, Mauer K. Definition and demographics of addiction. In: Kaye A, Vadivelu URD, editors. Substance abuse inpatient and outpatient management for every clinician. New York: Springer; 2015. p. 1–17.
2. Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitzation view. Addiction. 2000;95:91–11.
3. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr. Opin. Neurobiol. 2001;11(2):250–7. https://doi.org/10.1016/S0959-4388(00)00204-X.
4. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat. Neurosci. 2005;8(11):1458–63. https://doi.org/10.1038/nn1584.
5. Salem SS, Wahab MA, Shaheen MO, Husin NM. Cognitive impairment among drug abuser. An Egyptian study, Cairo University; 2003.